News | Ultrasound Imaging | August 10, 2022

Butterfly Files Motion to Dismiss Claims in FUJIFILM Sonosite Legal Action

Butterfly will defend itself vigorously against the allegations 

The SpeedBird and Concorde device platforms are based on TransMed7’s patented Zero5 work element composed of a fused, single element constructed from 3 hypotubes, laser cut and welded to form articulable twin cutter blades at the end of a rotating open tube

August 10, 2022 —  Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ultrasound, today filed a motion to dismiss claims and specific patents from a complaint for patent infringement lawsuit filed on March 9, 2022, by Fujifilm Sonosite Inc. Butterfly believes the lawsuit alleging infringement of U.S. Patent Nos. 7,169,108; 7,867,168; 8,128,050; 8,861,822; 9,538,985; 6,901,157; and 8,360,981, lacks merit and is meant to distract from Fujifilm Sonosite’s failure to innovate and keep pace with Butterfly’s next generation clinical assessment platform. 

As a transformative digital health company, Butterfly is shifting the healthcare industry from using ultrasound only in limited traditional settings, to using ultrasound information in all care settings, for any patient, and at any time. The company’s innovations include Butterfly iQ and iQ+, the world's first handheld, single probe whole-body ultrasound system using semiconductor technology that is transforming point of care ultrasound into an advanced clinical assessment tool, by making it intuitive, adoptable at scale, extremely portable, and economically appealing. 

Butterfly will vigorously defend against Fujifilm Sonosite’s accusations. In defending against this lawsuit, Butterfly will consider all means necessary and appropriate to eliminate obstacles to its mission to enable more informed clinical decisions for all patients worldwide. 

Butterfly’s Senior Vice President and Chief Legal Officer Larry Weiss said “We’re disappointed that Fujifilm Sonosite chose this approach. We believe this litigation is an attempt by Fujifilm Sonosite Inc. to distract from its failure to innovate and keep pace with Butterfly’s next generation clinical assessment platform. Our state of the art technology is the result of years of innovation, and is evidenced by our more than 800 patents and applications. We will continue to vigorously protect both our innovations and our intellectual property.” 

For more information: https://www.butterflynetwork.com/ 


Related Content

News | Cardiac Imaging

September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including ...

Home September 02, 2022
Home
News | Cardiac Imaging

September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...

Home September 02, 2022
Home
News | Cardiac Imaging

August 25, 2022 — Imperfect current propagation in the heart is at the root of most cardiac diseases. Thanks to a novel ...

Home August 25, 2022
Home
News | Cardiac Imaging

July 14, 2022 – AvoMD, a next-generation application-based clinical decision support platform, is working with the ...

Home July 14, 2022
Home
Feature | Cardiac Imaging | By Ronny Shalev, Ph.D.

Artificial intelligence’s (AI) applicability in cardiac imaging is rapidly growing and was a major topic of discussion ...

Home June 28, 2022
Home
News | Cardiac Imaging

June 24, 2022 — The Radiological Society of North America (RSNA) reports that Coronary Artery Calcium (CAC) scoring with ...

Home June 24, 2022
Home
News | Cardiac Imaging

June 23, 2022 — New research from the Smidt Heart Institute at Cedars-Sinai shows for the first time that the path ...

Home June 23, 2022
Home
News | Cardiac Imaging

May 2, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), routine visual ordinal coronary artery calcium ...

Home May 02, 2022
Home
News | Cardiac Imaging

April 11, 2022 — Radiation to the heart during treatment for locally advanced lung cancer is associated with an ...

Home April 11, 2022
Home
News | Cardiac Imaging
February 21, 2022 – Acute coronary syndromes (such as heart attacks) and strokes are a leading cause of morbidity and ...
Home February 21, 2022
Home
Subscribe Now